albendazole has been researched along with Schistosomiasis mansoni in 27 studies
Schistosomiasis mansoni: Schistosomiasis caused by Schistosoma mansoni. It is endemic in Africa, the Middle East, South America, and the Caribbean and affects mainly the bowel, spleen, and liver.
Excerpt | Relevance | Reference |
---|---|---|
" This study was conducted to assess whether the short form of the World Health Organization (WHO) QOL questionnaire (WHOQOL-BREF) was an effective tool for measuring morbidity due to Schistosoma mansoni infection and whether it could detect an impact of treatment with praziquantel." | 3.80 | Assessment of quality of life as a tool for measuring morbidity due to Schistosoma mansoni infection and the impact of treatment. ( Abudho, B; Blackstock, AJ; Foo, KT; Hightower, AW; Karanja, DM; Kennedy, ED; Montgomery, SP; Mwinzi, PN; Ochola, EA; Person, B; Secor, WE; Won, KY, 2014) |
" However, the optimal time points post-treatment for assessing the efficacy of praziquantel against Schistosoma mansoni and albendazole against hookworm infections are not known." | 3.75 | Sequential analysis of helminth egg output in human stool samples following albendazole and praziquantel administration. ( Allangba, A; Lohourignon, LK; N'Goran, EK; Scherrer, AU; Sjöberg, MK; Traoré, M; Tschannen, AB; Utzinger, J, 2009) |
"Praziquantel was not available in any of the HF." | 1.48 | Capacity gaps in health facilities for case management of intestinal schistosomiasis and soil-transmitted helminthiasis in Burundi. ( Bizimana, P; Muhimpundu, E; Ngenzebuhoro, C; Nsabiyumva, F; Ortu, G; Polman, K; Van Geertruyden, JP, 2018) |
"The overall prevalence and intensity of intestinal schistosomiasis among school children in Hayk Number 1 and Hayk Number 2 Primary Schools was found to be 45% and 161 epg, respectively." | 1.42 | A new focus of schistosomiasis mansoni in Hayk town, northeastern Ethiopia. ( Amsalu, G; Erko, B; Mekonnen, Z, 2015) |
"To control intestinal schistosomiasis at a national level in sub-Saharan Africa, there is a need for field-applicable markers to measure morbidity associated with this disease." | 1.36 | Intestinal schistosomiasis in mothers and young children in Uganda: investigation of field-applicable markers of bowel morbidity. ( Betson, M; Kabatereine, NB; Rowell, C; Sousa-Figueiredo, JC; Stothard, JR, 2010) |
"The effect of coinfection on HIV disease progression varied with species." | 1.32 | Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda. ( Brown, M; Elliott, AM; Hughes, P; Kizza, M; Quigley, MA; Rowland, S; Watera, C; Whitworth, JA, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (37.04) | 29.6817 |
2010's | 17 (62.96) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chami, GF | 1 |
Kabatereine, NB | 7 |
Tukahebwa, EM | 2 |
Nalwoga, A | 1 |
Webb, EL | 3 |
Chihota, B | 1 |
Miley, W | 1 |
Walusimbi, B | 1 |
Nassuuna, J | 1 |
Sanya, RE | 1 |
Nkurunungi, G | 1 |
Labo, N | 1 |
Elliott, AM | 4 |
Cose, S | 1 |
Whitby, D | 1 |
Newton, R | 1 |
Abudho, BO | 1 |
Ndombi, EM | 1 |
Guya, B | 1 |
Carter, JM | 1 |
Riner, DK | 1 |
Kittur, N | 1 |
Karanja, DMS | 1 |
Secor, WE | 3 |
Colley, DG | 1 |
Sircar, AD | 1 |
Mwinzi, PNM | 1 |
Onkanga, IO | 1 |
Wiegand, RE | 1 |
Montgomery, SP | 2 |
Bizimana, P | 1 |
Polman, K | 1 |
Van Geertruyden, JP | 1 |
Nsabiyumva, F | 1 |
Ngenzebuhoro, C | 1 |
Muhimpundu, E | 1 |
Ortu, G | 1 |
Hailu, T | 1 |
Abera, B | 1 |
Mulu, W | 1 |
Alemu, M | 1 |
Yizengaw, E | 1 |
Genanew, A | 1 |
Sammet, S | 1 |
Wieser, A | 1 |
Müller, S | 1 |
Huber, M | 1 |
Schubert, S | 1 |
Seybold, U | 1 |
Won, KY | 1 |
Abudho, B | 1 |
Blackstock, AJ | 1 |
Kennedy, ED | 1 |
Person, B | 1 |
Mwinzi, PN | 1 |
Ochola, EA | 1 |
Foo, KT | 1 |
Hightower, AW | 1 |
Karanja, DM | 1 |
Pinot de Moira, A | 2 |
Fitzsimmons, CM | 2 |
Jones, FM | 2 |
Wilson, S | 2 |
Cahen, P | 1 |
Tukahebwa, E | 4 |
Mpairwe, H | 2 |
Mwatha, JK | 2 |
Bethony, JM | 2 |
Skov, PS | 1 |
Dunne, DW | 2 |
Amsalu, G | 1 |
Mekonnen, Z | 1 |
Erko, B | 2 |
Nampijja, M | 1 |
Kaweesa, J | 1 |
Kizindo, R | 1 |
Namutebi, M | 1 |
Nakazibwe, E | 1 |
Oduru, G | 1 |
Kabuubi, P | 1 |
Kabagenyi, J | 1 |
Kizito, D | 2 |
Muhangi, L | 2 |
Akello, M | 1 |
Verweij, JJ | 1 |
Nerima, B | 1 |
Coelho, PM | 2 |
Siqueira, LM | 1 |
Grenfell, RF | 1 |
Almeida, NB | 1 |
Katz, N | 1 |
Almeida, Á | 1 |
Carneiro, NF | 1 |
Oliveira, E | 1 |
Scherrer, AU | 1 |
Sjöberg, MK | 1 |
Allangba, A | 1 |
Traoré, M | 1 |
Lohourignon, LK | 1 |
Tschannen, AB | 1 |
N'Goran, EK | 1 |
Utzinger, J | 1 |
Berhe, N | 1 |
Myrvang, B | 1 |
Gundersen, SG | 1 |
Enk, MJ | 1 |
Lima, AC | 1 |
Barros, Hda S | 1 |
Massara, CL | 1 |
Schall, VT | 1 |
Betson, M | 2 |
Sousa-Figueiredo, JC | 2 |
Rowell, C | 1 |
Stothard, JR | 4 |
Ndibazza, J | 1 |
Mawa, P | 1 |
Tweyongyere, R | 1 |
Muwanga, M | 1 |
Seto, EY | 1 |
Byalero, C | 1 |
Legesse, M | 1 |
Medhin, G | 1 |
Friis, H | 1 |
Mwaniki, D | 1 |
Omondi, B | 1 |
Muniu, E | 1 |
Thiong'o, F | 1 |
Ouma, J | 1 |
Magnussen, P | 1 |
Geissler, PW | 1 |
Michaelsen, KF | 1 |
Brown, M | 1 |
Kizza, M | 1 |
Watera, C | 1 |
Quigley, MA | 1 |
Rowland, S | 1 |
Hughes, P | 1 |
Whitworth, JA | 1 |
Kazibwe, F | 2 |
Namwangye, H | 1 |
Zaramba, S | 1 |
Brooker, S | 1 |
Kamenka, C | 1 |
Whawell, S | 2 |
Webster, JP | 2 |
Fenwick, A | 3 |
Koukounari, A | 1 |
Donnelly, CA | 1 |
Gabrielli, AF | 1 |
Touré, S | 1 |
Sellin, B | 1 |
Sellin, E | 1 |
Ky, C | 1 |
Ouedraogo, H | 1 |
Yaogho, M | 1 |
Wilson, MD | 1 |
Thompson, H | 1 |
Sanou, S | 1 |
Gazzinelli, A | 1 |
Hightower, A | 1 |
LoVerde, PT | 1 |
Haddad, JP | 1 |
Pereira, WR | 1 |
Bethony, J | 1 |
Correa-Oliveira, R | 1 |
Kloos, H | 1 |
Raja'a, YA | 1 |
Sulaiman, SM | 1 |
Mubarak, JS | 1 |
El-Bakri, MM | 1 |
Al-Adimi, WH | 1 |
El-Nabihi, MT | 1 |
El-Dhobri, MA | 1 |
Raja'a, JA | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Changes in HIV Viral Load in Patients Undergoing Treatment for Filarial Infection[NCT00344279] | 1,000 participants (Anticipated) | Observational | 2005-08-08 | Completed | |||
Can Anthelminthic Treatment Delay the Progression of HIV? Randomised Open-label Trial Testing Presumptive Anthelminthic Treatment on Progression of HIV in ART-naïve HIV-positive Patients in a Rural African Setting With Presumed High Prevalence of Helminth[NCT00817713] | 295 participants (Actual) | Interventional | 2009-01-31 | Terminated (stopped due to Terminated prematurely due to recruitment difficulties. Expansion to more study sites not planned.) | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
4 trials available for albendazole and Schistosomiasis mansoni
Article | Year |
---|---|
The Lake Victoria Island Intervention Study on Worms and Allergy-related diseases (LaVIISWA): study protocol for a randomised controlled trial.
Topics: Albendazole; Animals; Anthelmintics; Biomarkers; Clinical Protocols; Dermatitis, Atopic; Drug Admini | 2015 |
Treatment with anthelminthics during pregnancy: what gains and what risks for the mother and child?
Topics: Albendazole; Ancylostomatoidea; Anemia; Animals; Anthelmintics; Benzimidazoles; Birth Weight; Child; | 2011 |
Efficacy of alebendazole and mebendazole in the treatment of Ascaris and Trichuris infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Animals; Anthelmintics; Ascariasis; Ascaris | 2002 |
Effects on haemoglobin of multi-micronutrient supplementation and multi-helminth chemotherapy: a randomized, controlled trial in Kenyan school children.
Topics: Adolescent; Albendazole; Anemia; Animals; Anthelmintics; Ascariasis; Ascaris lumbricoides; Child; Di | 2003 |
23 other studies available for albendazole and Schistosomiasis mansoni
Article | Year |
---|---|
The division of labour between community medicine distributors influences the reach of mass drug administration: A cross-sectional study in rural Uganda.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Anthelmintics; Child; Child, Preschool; Community Hea | 2019 |
Kaposi's sarcoma-associated herpesvirus seropositivity is associated with parasite infections in Ugandan fishing communities on Lake Victoria islands.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Antibodies, Helminth; Antigens, Helminth; Child; Chil | 2019 |
Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study.
Topics: Adolescent; Albendazole; Animals; Anthelmintics; Child; Cross-Sectional Studies; Female; Humans; Ken | 2018 |
Topics: Albendazole; Animals; Anthelmintics; Child; Cohort Studies; Cross-Sectional Studies; Feces; Female; | 2018 |
Capacity gaps in health facilities for case management of intestinal schistosomiasis and soil-transmitted helminthiasis in Burundi.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Burundi; Case Management; Child; Endemic Dis | 2018 |
Efficacy of single dose albendazole and praziquantel drugs among helminth-infected school children at Rural Bahir Dar, northwest Ethiopia.
Topics: Adolescent; Albendazole; Animals; Anthelmintics; Child; Cross-Sectional Studies; Ethiopia; Feces; Fe | 2018 |
Triple worm infestation in an HIV-infected patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Anthelmintics; Appendicitis; Dic | 2013 |
Assessment of quality of life as a tool for measuring morbidity due to Schistosoma mansoni infection and the impact of treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Animals; Anthropometry; Feces; Female; Foll | 2014 |
Suppression of basophil histamine release and other IgE-dependent responses in childhood Schistosoma mansoni/hookworm coinfection.
Topics: Adolescent; Albendazole; Anthelmintics; Child; Histamine; Hookworm Infections; Humans; Immunoglobuli | 2014 |
A new focus of schistosomiasis mansoni in Hayk town, northeastern Ethiopia.
Topics: Adolescent; Albendazole; Animals; Anthelmintics; Biomphalaria; Child; Child, Preschool; Cross-Sectio | 2015 |
Improvement of POC-CCA Interpretation by Using Lyophilization of Urine from Patients with Schistosoma mansoni Low Worm Burden: Towards an Elimination of Doubts about the Concept of Trace.
Topics: Albendazole; Animals; Anthelmintics; Antigens, Helminth; Feces; Freeze Drying; Glycoproteins; Helmin | 2016 |
Sequential analysis of helminth egg output in human stool samples following albendazole and praziquantel administration.
Topics: Adolescent; Albendazole; Animals; Anthelmintics; Child; Child, Preschool; Feces; Female; Hookworm In | 2009 |
Gastro-intestinal symptoms associated with intense Schistosoma mansoni infection affect class-attentiveness of schoolchildren in Ethiopia.
Topics: Abdominal Pain; Adolescent; Albendazole; Animals; Anthelmintics; Attention; Child; Cross-Sectional S | 2009 |
Factors related to transmission of and infection with Schistosoma mansoni in a village in the South-eastern Region of Brazil.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Animals; Biomphalaria; Brazil; Child; Child | 2010 |
Intestinal schistosomiasis in mothers and young children in Uganda: investigation of field-applicable markers of bowel morbidity.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Child; Child, Preschool; Feces; Female; Humans; | 2010 |
Effects of treatment on IgE responses against parasite allergen-like proteins and immunity to reinfection in childhood schistosome and hookworm coinfections.
Topics: Adolescent; Albendazole; Allergens; Ancylostomatoidea; Animals; Antibodies, Helminth; Antigens, Helm | 2013 |
Patterns of intestinal schistosomiasis among mothers and young children from Lake Albert, Uganda: water contact and social networks inferred from wearable global positioning system dataloggers.
Topics: Albendazole; Animals; Anthelmintics; Cercaria; Child; Child, Preschool; Environmental Exposure; Fema | 2012 |
Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda.
Topics: Adult; Albendazole; Ancylostomatoidea; Animals; Anthelmintics; CD4 Lymphocyte Count; Disease Progres | 2004 |
Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda.
Topics: Adult; Albendazole; Ancylostomatoidea; Animals; Anthelmintics; CD4 Lymphocyte Count; Disease Progres | 2004 |
Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda.
Topics: Adult; Albendazole; Ancylostomatoidea; Animals; Anthelmintics; CD4 Lymphocyte Count; Disease Progres | 2004 |
Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda.
Topics: Adult; Albendazole; Ancylostomatoidea; Animals; Anthelmintics; CD4 Lymphocyte Count; Disease Progres | 2004 |
Progress towards countrywide control of schistosomiasis and soil-transmitted helminthiasis in Uganda.
Topics: Adolescent; Albendazole; Anthelmintics; Child; Child, Preschool; Health Care Costs; Helminthiasis; H | 2006 |
Morbidity indicators of Schistosoma mansoni: relationship between infection and anemia in Ugandan schoolchildren before and after praziquantel and albendazole chemotherapy.
Topics: Adolescent; Albendazole; Anemia; Animals; Anthelmintics; Child; Feces; Female; Hemoglobins; Humans; | 2006 |
A combined school- and community-based campaign targeting all school-age children of Burkina Faso against schistosomiasis and soil-transmitted helminthiasis: performance, financial costs and implications for sustainability.
Topics: Adolescent; Albendazole; Animals; Anthelmintics; Burkina Faso; Child; Child, Preschool; Drug Costs; | 2006 |
The spatial distribution of Schistosoma mansoni infection before and after chemotherapy in the Jequitinhonha Valley in Brazil.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Brazil; Child; Child, Preschool; Feces; Fema | 2006 |
Some aspects in the control of schistosomosis and soil-transmitted helminthosis in Yemeni children.
Topics: Adolescent; Albendazole; Analysis of Variance; Anthelmintics; Antiprotozoal Agents; Child; Child, Pr | 2001 |